These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 9398212)

  • 21. Tenascin cytotactin epidermal growth factor-like repeat binds epidermal growth factor receptor with low affinity.
    Iyer AK; Tran KT; Borysenko CW; Cascio M; Camacho CJ; Blair HC; Bahar I; Wells A
    J Cell Physiol; 2007 Jun; 211(3):748-58. PubMed ID: 17311283
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Epidermal growth factor receptor dimerization monitored in live cells.
    Blakely BT; Rossi FM; Tillotson B; Palmer M; Estelles A; Blau HM
    Nat Biotechnol; 2000 Feb; 18(2):218-22. PubMed ID: 10657132
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Surface-anchoring of spontaneously dimerized epidermal growth factor for highly selective expansion of neural stem cells.
    Nakaji-Hirabayashi T; Kato K; Iwata H
    Bioconjug Chem; 2009 Jan; 20(1):102-10. PubMed ID: 19154156
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Highly polarized EGF receptor tyrosine kinase activity initiates egg activation in Xenopus.
    Yim DL; Opresko LK; Wiley HS; Nuccitelli R
    Dev Biol; 1994 Mar; 162(1):41-55. PubMed ID: 8125197
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Modeling the epidermal growth factor -- epidermal growth factor receptor l2 domain interaction: implications for the ligand binding process.
    Jorissen RN; Treutlein HR; Epa VC; Burgess AW
    J Biomol Struct Dyn; 2002 Jun; 19(6):961-72. PubMed ID: 12023799
    [TBL] [Abstract][Full Text] [Related]  

  • 26. 5'-(p-fluorosulfonylbenzoyl)-2'(or 3')-(methylanthraniloyl)adenosine, fluorescent affinity labels for adenine nucleotide binding sites: interaction with the kinase active site of the receptor for epidermal growth factor.
    Scoggins RM; Summerfield AE; Stein RA; Guyer CA; Staros JV
    Biochemistry; 1996 Jul; 35(28):9197-203. PubMed ID: 8703925
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Epidermal growth factor receptors lose ligand binding ability as WI-38 cells progress from short-term to long-term quiescence.
    Donigan AM; Cavalli RC; Pena AA; Savage CR; Soprano DR; Soprano KJ
    J Cell Physiol; 1993 Apr; 155(1):164-70. PubMed ID: 8468362
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of sulfhydryl modification reagents on the kinase activity of the epidermal growth factor receptor.
    Woltjer RL; Staros JV
    Biochemistry; 1997 Aug; 36(32):9911-6. PubMed ID: 9245424
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Purification and assay of kinase-active EGF receptor from mammalian cells by immunoaffinity chromatography.
    Wiepz GJ; Guadaramma AG; Fulgham DL; Bertics PJ
    Methods Mol Biol; 2006; 327():25-38. PubMed ID: 16780210
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Sphingolipid regulation of the epidermal growth factor receptor.
    Davis RJ
    Adv Lipid Res; 1993; 25():131-45. PubMed ID: 8396310
    [No Abstract]   [Full Text] [Related]  

  • 31. [The phosphorylation and tyrosine kinase activity of an internalized complex of epidermal growth factor and its receptor].
    Reshetnikova GF; Nesterov AM; Nikol'skiĭ NN
    Tsitologiia; 1990; 32(2):140-7. PubMed ID: 2368159
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Discovery of improved EGF agonists using a novel in vitro screening platform.
    Lui BH; Cochran JR; Swartz JR
    J Mol Biol; 2011 Oct; 413(2):406-15. PubMed ID: 21888916
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ligand-binding enhances the affinity of dimerization of the extracellular domain of the epidermal growth factor receptor.
    Odaka M; Kohda D; Lax I; Schlessinger J; Inagaki F
    J Biochem; 1997 Jul; 122(1):116-21. PubMed ID: 9276679
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evaluation of dimerization-inhibitory activities of cyclic peptides containing a β-hairpin loop sequence of the EGF receptor.
    Mizuguchi T; Ohara N; Iida M; Ninomiya R; Wada S; Kiso Y; Saito K; Akaji K
    Bioorg Med Chem; 2012 Oct; 20(19):5730-7. PubMed ID: 22959765
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The use of optical techniques to detect conformational changes associated with the interaction of epidermal growth factor and its receptor.
    Waterfield MD; Greenfield C; Hiles I; Federwisch M; Wollmer A; Blundell TL; McDonald N
    Adv Second Messenger Phosphoprotein Res; 1990; 24():301-6. PubMed ID: 2119642
    [No Abstract]   [Full Text] [Related]  

  • 36. [Epidermal growth factor receptor].
    Odaka M; Inagaki F
    Tanpakushitsu Kakusan Koso; 1994 May; 39(7):1161-7. PubMed ID: 8016345
    [No Abstract]   [Full Text] [Related]  

  • 37. On the nature of low- and high-affinity EGF receptors on living cells.
    Ozcan F; Klein P; Lemmon MA; Lax I; Schlessinger J
    Proc Natl Acad Sci U S A; 2006 Apr; 103(15):5735-40. PubMed ID: 16571657
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Epidermal growth factor and its receptor: the structure and function].
    Gamou S; Shimizu N
    Nihon Rinsho; 1992 Aug; 50(8):1885-92. PubMed ID: 1433980
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Signal transmission by epidermal growth factor receptor: coincidence of activation and dimerization.
    Canals F
    Biochemistry; 1992 May; 31(18):4493-501. PubMed ID: 1316148
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Purification of the EGF receptor for oligosaccharide studies.
    Gregoriou M
    Methods Mol Biol; 1993; 14():189-98. PubMed ID: 8348235
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.